An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

Matthew P R Berry, Christine M. Graham, Finlay W. McNab, Zhaohui Xu, Susannah A A Bloch, Tolu Oni, Katalin A. Wilkinson, Romain Banchereau, Jason Skinner, Robert J. Wilkinson, Charles Quinn, Derek Blankenship, Ranju Dhawan, John J. Cush, Asuncion Mejias, Octavio Ramilo, Onn M. Kon, Virginia Pascual, Jacques Banchereau, Damien J. ChaussabelAnne O'Garra

Research output: Contribution to journalArticle

968 Citations (Scopus)

Abstract

Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines. Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-γ and type I IFN-αβ signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-αβ signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.

Original languageEnglish
Pages (from-to)973-977
Number of pages5
JournalNature
Volume466
Issue number7309
DOIs
Publication statusPublished - 19 Aug 2010
Externally publishedYes

Fingerprint

Interferons
Tuberculosis
Neutrophils
Interferon Type I
Mycobacterium tuberculosis
Latent Tuberculosis
Active Immunotherapy
Plasma Cells
Systemic Lupus Erythematosus
Communicable Diseases
Therapeutics
Vaccines
Biomarkers
Morbidity
Gene Expression
Mortality
Infection

ASJC Scopus subject areas

  • General
  • Medicine(all)

Cite this

Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., ... O'Garra, A. (2010). An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature, 466(7309), 973-977. https://doi.org/10.1038/nature09247

An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. / Berry, Matthew P R; Graham, Christine M.; McNab, Finlay W.; Xu, Zhaohui; Bloch, Susannah A A; Oni, Tolu; Wilkinson, Katalin A.; Banchereau, Romain; Skinner, Jason; Wilkinson, Robert J.; Quinn, Charles; Blankenship, Derek; Dhawan, Ranju; Cush, John J.; Mejias, Asuncion; Ramilo, Octavio; Kon, Onn M.; Pascual, Virginia; Banchereau, Jacques; Chaussabel, Damien J.; O'Garra, Anne.

In: Nature, Vol. 466, No. 7309, 19.08.2010, p. 973-977.

Research output: Contribution to journalArticle

Berry, MPR, Graham, CM, McNab, FW, Xu, Z, Bloch, SAA, Oni, T, Wilkinson, KA, Banchereau, R, Skinner, J, Wilkinson, RJ, Quinn, C, Blankenship, D, Dhawan, R, Cush, JJ, Mejias, A, Ramilo, O, Kon, OM, Pascual, V, Banchereau, J, Chaussabel, DJ & O'Garra, A 2010, 'An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis', Nature, vol. 466, no. 7309, pp. 973-977. https://doi.org/10.1038/nature09247
Berry MPR, Graham CM, McNab FW, Xu Z, Bloch SAA, Oni T et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature. 2010 Aug 19;466(7309):973-977. https://doi.org/10.1038/nature09247
Berry, Matthew P R ; Graham, Christine M. ; McNab, Finlay W. ; Xu, Zhaohui ; Bloch, Susannah A A ; Oni, Tolu ; Wilkinson, Katalin A. ; Banchereau, Romain ; Skinner, Jason ; Wilkinson, Robert J. ; Quinn, Charles ; Blankenship, Derek ; Dhawan, Ranju ; Cush, John J. ; Mejias, Asuncion ; Ramilo, Octavio ; Kon, Onn M. ; Pascual, Virginia ; Banchereau, Jacques ; Chaussabel, Damien J. ; O'Garra, Anne. / An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. In: Nature. 2010 ; Vol. 466, No. 7309. pp. 973-977.
@article{565b8c875a754b029611d6e6d1641f6a,
title = "An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis",
abstract = "Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10{\%} lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines. Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-γ and type I IFN-αβ signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-αβ signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.",
author = "Berry, {Matthew P R} and Graham, {Christine M.} and McNab, {Finlay W.} and Zhaohui Xu and Bloch, {Susannah A A} and Tolu Oni and Wilkinson, {Katalin A.} and Romain Banchereau and Jason Skinner and Wilkinson, {Robert J.} and Charles Quinn and Derek Blankenship and Ranju Dhawan and Cush, {John J.} and Asuncion Mejias and Octavio Ramilo and Kon, {Onn M.} and Virginia Pascual and Jacques Banchereau and Chaussabel, {Damien J.} and Anne O'Garra",
year = "2010",
month = "8",
day = "19",
doi = "10.1038/nature09247",
language = "English",
volume = "466",
pages = "973--977",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7309",

}

TY - JOUR

T1 - An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis

AU - Berry, Matthew P R

AU - Graham, Christine M.

AU - McNab, Finlay W.

AU - Xu, Zhaohui

AU - Bloch, Susannah A A

AU - Oni, Tolu

AU - Wilkinson, Katalin A.

AU - Banchereau, Romain

AU - Skinner, Jason

AU - Wilkinson, Robert J.

AU - Quinn, Charles

AU - Blankenship, Derek

AU - Dhawan, Ranju

AU - Cush, John J.

AU - Mejias, Asuncion

AU - Ramilo, Octavio

AU - Kon, Onn M.

AU - Pascual, Virginia

AU - Banchereau, Jacques

AU - Chaussabel, Damien J.

AU - O'Garra, Anne

PY - 2010/8/19

Y1 - 2010/8/19

N2 - Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines. Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-γ and type I IFN-αβ signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-αβ signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.

AB - Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with diagnosis, prevention and treatment. Most people infected with M. tuberculosis remain asymptomatic, termed latent TB, with a 10% lifetime risk of developing active TB disease. Current tests, however, cannot identify which individuals will develop disease. The immune response to M. tuberculosis is complex and incompletely characterized, hindering development of new diagnostics, therapies and vaccines. Here we identify a whole-blood 393 transcript signature for active TB in intermediate and high-burden settings, correlating with radiological extent of disease and reverting to that of healthy controls after treatment. A subset of patients with latent TB had signatures similar to those in patients with active TB. We also identify a specific 86-transcript signature that discriminates active TB from other inflammatory and infectious diseases. Modular and pathway analysis revealed that the TB signature was dominated by a neutrophil-driven interferon (IFN)-inducible gene profile, consisting of both IFN-γ and type I IFN-αβ signalling. Comparison with transcriptional signatures in purified cells and flow cytometric analysis suggest that this TB signature reflects changes in cellular composition and altered gene expression. Although an IFN-inducible signature was also observed in whole blood of patients with systemic lupus erythematosus (SLE), their complete modular signature differed from TB, with increased abundance of plasma cell transcripts. Our studies demonstrate a hitherto underappreciated role of type I IFN-αβ signalling in the pathogenesis of TB, which has implications for vaccine and therapeutic development. Our study also provides a broad range of transcriptional biomarkers with potential as diagnostic and prognostic tools to combat the TB epidemic.

UR - http://www.scopus.com/inward/record.url?scp=77955894773&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955894773&partnerID=8YFLogxK

U2 - 10.1038/nature09247

DO - 10.1038/nature09247

M3 - Article

C2 - 20725040

AN - SCOPUS:77955894773

VL - 466

SP - 973

EP - 977

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7309

ER -